- Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old children2015 | Publication without faculty affiliation
- A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I) Effects of prophylactic paracetamol on immunogenicity and reactogenicity of routine infant vaccines and 4CMenB2014 | Publication without faculty affiliation
- A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II) Effects of variations of the OMV and protein content on immunogenicity and reactogenicity2014 | Publication without faculty affiliation
- Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age2016 | Publication without faculty affiliation
- Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2-or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months2021 | Publication without faculty affiliation
- Infection by Neisseria meningitidis serogroup W135 belonging to the unusual clone ST-3342 in the Czech Republic2013 | Faculty of Medicine in Pilsen
- Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Wtihout Routine Infant Vaccinations According to Different Immunization Schedules A Randomized Controlled Trial2012 | Publication without faculty affiliation
- Molecular characterization of serogroup 19 Streptococcus pneumoniae in the Czech Republic in the post-vaccine era2018 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Corrigendum: Molecular characterization of serogroup 19 Streptococcus pneumoniae in the Czech Republic in the post-vaccine era (vol 67, pg 1003, 2018)2018 | Faculty of Medicine in Hradec Králové
- Identification and characterisation of Escherichia coli strains of O157 and non-O157 serogroups containing three distinct Shiga toxin genes2000 | Second Faculty of Medicine
- Analysis of epidemiological and molecular data from invasive meningococcal disease surveillance in the Czech Republic, 1993–20202022 | First Faculty of Medicine, Central Library of Charles University
- Invasive meningococcal disease and updates in the vaccine reimbursement since January 1, 20222022 | Faculty of Medicine in Hradec Králové
- Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials2013 | Publication without faculty affiliation
- Laboratory diagnostics of Shiga toxin-producing E. coli in the National Reference Laboratory for E. coli and Shigella and methodological guideliness for clinical laboratories2022 | Second Faculty of Medicine
- Analysis of meningococcal vaccine uptake in patients with invasive meningococcal disease, Czech Republic, 2006-20222023 | First Faculty of Medicine, Central Library of Charles University
- Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020)2023 | First Faculty of Medicine, Central Library of Charles University
- First experience with detecting bacterial DNA in the cerebrospinal fluid of patients with purulent meningitis using broad spectrum multiplex nested PCR2007 | Second Faculty of Medicine, Third Faculty of Medicine
- Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study2018 | Faculty of Medicine in Hradec Králové
- Whole genome sequencing of Neisseria meningitidis Y isolates collected in the Czech Republic in 1993-20182022 | First Faculty of Medicine, Central Library of Charles University
- Non-O157 : H7 Shiga toxin (verocytotoxin)-producing Escherichia coli strains: epidemiological significance and microbiological diagnosis2000 | Second Faculty of Medicine
- Quadrivalent meningococcal vaccine conjugated to protein CRM2010 | Publication without faculty affiliation
- Invasive meningococcal diseases2011 | Faculty of Medicine in Hradec Králové
- Acute Pneumonia Caused by Clinically Isolated Legionella pneumophila Sg 1, ST 62: Host Responses and Pathologies in Mice2022 | Second Faculty of Medicine
- Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains2000 | Second Faculty of Medicine
- Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic1996 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Enterohemorrhagic Escherichia coli as the cause of diarrhea in the Czech Republic, 1965-20132014 | First Faculty of Medicine